etomoxir has been researched along with cp 724714 in 1 studies
| Studies (etomoxir) | Trials (etomoxir) | Recent Studies (post-2010) (etomoxir) | Studies (cp 724714) | Trials (cp 724714) | Recent Studies (post-2010) (cp 724714) |
|---|---|---|---|---|---|
| 260 | 8 | 93 | 27 | 3 | 19 |
| Protein | Taxonomy | etomoxir (IC50) | cp 724714 (IC50) |
|---|---|---|---|
| Epidermal growth factor receptor | Homo sapiens (human) | 6.4 | |
| Receptor tyrosine-protein kinase erbB-2 | Homo sapiens (human) | 0.014 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aleo, MD; Bonin, PD; Luo, Y; Potter, DM; Swiss, R; Will, Y | 1 |
1 other study(ies) available for etomoxir and cp 724714
| Article | Year |
|---|---|
Human drug-induced liver injury severity is highly associated with dual inhibition of liver mitochondrial function and bile salt export pump.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Chemical and Drug Induced Liver Injury; Humans; Male; Mitochondria, Liver; Rats; Rats, Sprague-Dawley; Severity of Illness Index | 2014 |